Mannan-Abeta<sub>28 </sub>conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) mice
<p>Abstract</p> <p>Background</p> <p>New pre-clinical trials in AD mouse models may help to develop novel immunogen-adjuvant configurations with the potential to avoid the adverse responses that occurred during the clinical trials with AN-1792 vaccine formulation. Recen...
Main Authors: | Karapetyan Adrine, Vasilevko Vitaly, Ajdari Rodmehr, Movsesyan Nina, Mamikonyan Grigor, Mkrtichyan Mikayel, Ghochikyan Anahit, Petrushina Irina, Lees Andrew, Agadjanyan Michael G, Cribbs David H |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-09-01
|
Series: | Journal of Neuroinflammation |
Online Access: | http://www.jneuroinflammation.com/content/5/1/42 |
Similar Items
-
Is Abeta a sufficient Biomarker for monitoring anti-Abeta clinical studies? A critical review.
by: Jens eMoreth, et al.
Published: (2013-07-01) -
Reducing AD-like pathology in 3xTg-AD mouse model by DNA epitope vaccine - a novel immunotherapeutic strategy.
by: Nina Movsesyan, et al.
Published: (2008-05-01) -
Abeta amyloid deposition in the language system and how the brain responds.
by: Nelissen, N, et al.
Published: (2007) -
Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies.
by: Ballard, C, et al.
Published: (2007) -
Sequestration of the Abeta peptide prevents toxicity and promotes degradation in vivo.
by: Leila M Luheshi, et al.
Published: (2010-03-01)